September 25, 2026

Cel-Sci Corporation (CVM) Stock Analysis: Exploring a 626% Upside Potential in Biotech

Cel-Sci Corporation (NASDAQ: CVM) presents a captivating opportunity for investors intrigued by the potential of biotechnology firms within the healthcare sector. With a market capitalization standing..

Trevi Therapeutics, Inc. (TRVI) Stock Analysis: Exploring a 92% Upside Potential in Biotech

Trevi Therapeutics, Inc. (NASDAQ: TRVI), a biotechnology company focused on innovating treatments for chronic coughs, presents an intriguing investment opportunity for those interested in the healthcare..

Embecta Corp. (EMBC) Stock Analysis: Exploring the Healthcare Innovator’s Potential Despite a 28.83% Downside

As investors continue to navigate the complexities of the healthcare sector, Embecta Corp. (EMBC) presents a compelling case for analysis. With its roots firmly planted in..

Replimune Group, Inc. (REPL) Stock Analysis: Exploring a 54.76% Potential Upside in Biotechnology

Replimune Group, Inc. (NASDAQ: REPL), a promising player in the biotechnology sector, is attracting attention from investors with its innovative approach to cancer treatment. Based in..

Stoke Therapeutics, Inc. (STOK) Stock Analysis: Exploring an 83.72% Potential Upside

Stoke Therapeutics, Inc. (NASDAQ: STOK) stands at an intriguing crossroads for investors with its innovative approach to tackling severe genetic diseases. The company’s focus on upregulating..

Verastem, Inc. (VSTM) Stock Analysis: Exploring an 88% Potential Upside in the Biotech Sector

Verastem, Inc. (NASDAQ: VSTM) is attracting significant attention among investors in the biotechnology sector, driven primarily by its robust potential upside of 88.03%, as suggested by..

Tilray Brands, Inc. (TLRY) Stock Analysis: Exploring an 80% Potential Upside in the Cannabis Market

Tilray Brands, Inc. (NASDAQ: TLRY) has become a focal point for investors eyeing the burgeoning cannabis industry. With its recent price of $4.07 and a market..

MeiraGTx Holdings plc (MGTX) Stock Analysis: A 151% Potential Upside in the Biotechnology Sphere

MeiraGTx Holdings plc (NASDAQ: MGTX), a clinical-stage genetic medicines company, is making waves in the biotechnology sector with its innovative approach to treating serious diseases. With..

SIGA Technologies Inc. (SIGA) Stock Analysis: Unveiling the Potential in the Healthcare Sector

SIGA Technologies Inc. (NASDAQ: SIGA), a key player in the healthcare sector, specializes in the development of antiviral drugs, most notably TPOXX, which targets human smallpox..

Sionna Therapeutics, Inc. (SION) Stock Analysis: Exploring a Potential 301% Upside in the Biotech Space

Sionna Therapeutics, Inc. (NASDAQ: SION), a clinical-stage biopharmaceutical company, has been drawing attention in the biotech sector with its promising pipeline for treating cystic fibrosis (CF)...

Autolus Therapeutics (AUTL) Stock Analysis: Unveiling a 356% Potential Upside in the Biotech Arena

Autolus Therapeutics plc (NASDAQ: AUTL), a promising player in the biotechnology sector, is capturing investor attention with its substantial growth potential. Headquartered in London, this clinical-stage..

Akso Health Group (AHG) Stock Analysis: Navigating the Challenges in China’s Medical Distribution Sector

Akso Health Group (NASDAQ: AHG), headquartered in Qingdao, China, operates within the healthcare sector, specifically focusing on medical distribution. Despite its diversified portfolio of products and..

Geron Corporation (GERN) Stock Analysis: A Biotech Gem with 237% Upside Potential

Geron Corporation (NASDAQ: GERN), a biopharmaceutical company entrenched in the cutting-edge field of oncology therapeutics, is capturing the attention of investors with its robust pipeline and..

Niagen Bioscience, Inc. (NAGE) Stock Analysis: Potential 301% Upside with Strong Buy Ratings

Niagen Bioscience, Inc. (NAGE), a company nestled within the Consumer Defensive sector, is capturing investor attention with its substantial potential upside and robust analyst endorsements. Operating..

Definitive Healthcare Corp. (DH) Stock Analysis: Unpacking the 88% Potential Upside

Definitive Healthcare Corp. (NASDAQ: DH) stands as a dynamic player in the healthcare sector, specifically within the health information services industry. The company, headquartered in Framingham,..

Community Health Systems, Inc. (CYH) Stock Analysis: Navigating Challenges with a Potential 9.59% Upside

Community Health Systems, Inc. (NYSE: CYH), headquartered in Franklin, Tennessee, is a prominent player in the healthcare sector, specifically within the medical care facilities industry. With..

Kura Oncology, Inc. (KURA) Stock Analysis: Exploring a Potential 194.66% Upside in the Biotech Sphere

Kura Oncology, Inc. (NASDAQ: KURA), a prominent player in the biotechnology sector, is drawing attention from investors on account of its promising pipeline and potential for..

Arvinas, Inc. (ARVN) Stock Analysis: Exploring an 78.80% Upside Potential in the Biotech Sector

Arvinas, Inc. (ARVN), a promising player in the biotechnology industry, has been making waves with its innovative approach to drug development. As a clinical-stage biotech firm,..

Inventiva S.A. (IVA) Stock Analysis: Exploring the Biotech’s 356% Upside Potential and Strong Buy Ratings

Inventiva S.A. (IVA), a clinical-stage biopharmaceutical company listed on the American Depository market, is making waves in the healthcare sector, particularly within the biotechnology industry. Headquartered..

Valneva SE (VALN) Stock Analysis: Is a 96.95% Upside Within Reach for This Biotech Pioneer?

Valneva SE (VALN), a France-based biotechnology company specializing in vaccines, stands at a crossroads that could spell a significant opportunity for investors. With a market capitalization..

Search

Funds

September 25, 2026

Search

Funds

September 25, 2026

FTSE 100

Funds